Integrated analysis for two randomized phase III studies comparing Taxotere at 75 mg/m2 and 100 mg/m2 to control regimens in non-small cell lung cancer (NSCLC) patients previously treated with a platinum-based chemotherapy
Y.P Kim, Gary G. Koch, Frances A. Shepherd et al. · Lung Cancer · 2000
Cited by 0 works. doi:10.1016/s0169-5002(00)80192-0